Can I undergo a contrast-enhanced CT scan while taking metformin?

Metformin is a common hypoglycemic medication, available in various dosage forms such as tablets and capsules. Generally, patients taking metformin should not undergo contrast-enhanced CT scans. The specific explanation is as follows:

Metformin is frequently used in the treatment of type 2 diabetes. It primarily controls blood glucose levels by reducing hepatic glycogen production and enhancing glucose utilization in muscles. The drug is excreted through the kidneys. During contrast-enhanced CT scans, iodine-containing contrast agents are injected, which are also excreted via the kidneys. Metformin and the contrast agent may interact within the kidneys, potentially hindering the excretion of metformin and causing it to accumulate in the kidneys. Therefore, undergoing contrast-enhanced CT scans while taking metformin is not recommended.

Prior to the examination, doctors usually advise patients to temporarily discontinue metformin or opt for alternative diagnostic methods instead of contrast-enhanced CT to ensure patient safety. Typically, metformin should be discontinued for 48 hours before and after the contrast-enhanced CT scan to reduce the risk of complications.

It is recommended that patients drink an appropriate amount of warm water after contrast-enhanced CT scans to accelerate metabolism and help eliminate residual medication from the body more quickly.